HPE
55
11
AIG
38
-4
EXC
54
-2
ROK
55
8
WDC
41
-2
HON
65
-2
DVN
16
3
SYK
64
-4
ACN
47
-2
IPG
49
10
ILMN
32
-3
DD
56
3
F
43
-8
XOM
47
5
EL
20
3
DLTR
34
-4
WAT
47
5
T
50
3
HUM
48
6
ZTS
47
2
HPE
55
11
AIG
38
-4
EXC
54
-2
ROK
55
8
WDC
41
-2
HON
65
-2
DVN
16
3
SYK
64
-4
ACN
47
-2
IPG
49
10
ILMN
32
-3
DD
56
3
F
43
-8
XOM
47
5
EL
20
3
DLTR
34
-4
WAT
47
5
T
50
3
HUM
48
6
ZTS
47
2
Financhill
Back

Matinas BioPharma Holdings Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38

MTNB
Matinas BioPharma Holdings

Last Price:
0.58
Seasonality Move:
5.28%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Matinas BioPharma Holdings Price Quote

$0.58
+0.04 (+7.41%)
(Updated: November 21, 2024 at 5:55 PM ET)

Matinas BioPharma Holdings Key Stats

Sell
38
Matinas BioPharma Holdings (MTNB) is a Sell
Day range:
$0.54 - $0.58
52-week range:
$0.50 - $21.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.67
P/B ratio:
0.2%
Volume:
66K
Avg. volume:
391.2K
1-year change:
-95.38%
Market cap:
$3.1M
Revenue:
$1.1M
EPS:
$-4.79

How Much Does Matinas BioPharma Holdings Make?

Data Unavailable

Is Matinas BioPharma Holdings Growing As A Company?

Data Unavailable

Matinas BioPharma Holdings Stock Price Performance

What Is Matinas BioPharma Holdings 52-Week High & Low?

Matinas BioPharma Holdings Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Matinas BioPharma Holdings?

Is Matinas BioPharma Holdings Cash Flow Positive?

  • What Is MTNB Cash Flow From Operations?
    Cash flow from operations (TTM) is -$17M
  • What Is Matinas BioPharma Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $9.2M
  • What Is Matinas BioPharma Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $11.7M

Matinas BioPharma Holdings Return On Invested Capital

Data Unavailable

Matinas BioPharma Holdings Earnings Date & Stock Price

Matinas BioPharma Holdings Competitors

Matinas BioPharma Holdings Dividend Yield

Matinas BioPharma Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 19.43%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 30.00
Upside from Last Price: 5455.56%

Major Shareholders

  • How many MTNB shares are owned by institutional investors?
    27.4M MTNB shares are owned by institutional investors
  • How many MTNB shares are owned by insiders?
    11.3M MTNB shares are owned by insiders